TAMMY YOUNG: Open Payments
NPI 1962090548 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| ABBVIE INC. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: CAPLYTA, COBENFY, REXULTI, VRAYLAR, INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, VIVITROL.
Industry payments across MA — which companies pay providers there.
